Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer

Figure 4

The comparison between the miRNA-based OS/RFS classifiers and clinical pathological features. (a) The hazard ratio of enrolled clinicopathological features and 17-miRNA-based OS classifiers in the overall set, respectively. (b) A hazard ratio of enrolled clinicopathological features and 13-miRNA-based RFS classifiers in the overall set, respectively.

(a)

(b)